https://pharminent.com/keenova-eyes-xiaflex-as-first-drug-for-plantar-fibromatosis/ 2026-07-09T15:13:38Z Pharminent en Keenova eyes Xiaflex as first drug for plantar fibromatosis 2026-07-09T12:47:57Z Blog https://pharminent.com/fda-warning-letter-hits-sanofis-genzyme-ireland-site/ 2026-07-08T20:33:20Z Pharminent en FDA Warning Letter Hits Sanofi's Genzyme Ireland Site 2026-07-08T20:33:04Z Blog https://pharminent.com/sino-biopharm-strikes-drug-licensing-deal-with-astrazeneca-deepens-partnership-with-gsk/ 2026-07-08T20:14:03Z Pharminent en Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK 2026-07-08T20:02:37Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-july-8-2026/ 2026-07-08T17:45:17Z Pharminent en Manufacturing Intelligence • Weekly Digest • July 8, 2026 2026-07-08T17:45:15Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-8-2026/ 2026-07-08T15:58:22Z Pharminent en Strategic News Watch • July 8, 2026 2026-07-08T15:58:20Z Blog https://pharminent.com/astrazeneca-gsk-intensify-china-ties-with-sino-biopharm-deals/ 2026-07-09T15:13:15Z Pharminent en AstraZeneca, GSK intensify China ties with Sino Biopharm deals 2026-07-08T15:58:00Z Blog https://pharminent.com/novartis-pays-1-1b-upfront-for-myricx-bio-adc-platform/ 2026-07-07T20:54:08Z Pharminent en Novartis Pays $1.1B Upfront for Myricx Bio ADC Platform 2026-07-07T20:54:08Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-july-7-2026/ 2026-07-07T20:29:19Z Pharminent en Oncology Intelligence Digest • July 7, 2026 2026-07-07T20:29:17Z Blog https://pharminent.com/veras-trutakna-wins-fda-accelerated-approval-for-iga-nephropathy/ 2026-07-08T03:43:48Z Pharminent en Vera's TRUTAKNA Wins FDA Accelerated Approval for IgA Nephropathy 2026-07-07T18:52:11Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-7-2026/ 2026-07-07T15:39:14Z Pharminent en Strategic News Watch • July 7, 2026 2026-07-07T15:39:12Z Blog https://pharminent.com/vertex-buys-crinetics-for-10bn-in-endocrinology-drive/ 2026-07-08T12:38:06Z Pharminent en Vertex buys Crinetics for $10bn in endocrinology drive 2026-07-07T09:08:31Z Blog https://pharminent.com/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-2/ 2026-07-07T17:20:57Z Pharminent en EC approves AbbVie's Tepkinly combination for follicular lymphoma 2026-07-07T08:54:07Z Blog